Recent Developments in EU Merger Remedies

摘要

Over a decade has passed since the Commission published the Merger Remedies Study, which found around one-third of the remedies evaluated to have been wholly or partially ineffective.1 Subsequent empirical studies covering the Commission's early merger control practice supported the notion that EU merger remedies sometimes failed to preserve effective competition in the affected markets,2 for reasons including inadequate scope of the divestment business, unsuitable purchasers, and insufficient cooperation from third parties.